ArticleDEN open2026
Enhanced Endoscope is Associated With Success Rates in B2- Endoscopic Ultrasound-Guided Hepaticogastrostomy.
Article in DEN open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Endoscopic ultrasound (EUS)-guided hepaticogastrostomy (HGS) in intrahepatic bile duct segment 3 (B3) is widely used for biliary drainage. Post-puncture procedures are easy to perform in intrahepatic bile duct segment 2 (B2), but using a conventional oblique-viewing (OV) scope (GF-UCT260) may result in transesophageal puncture. In this study, we compared the safety and efficacy of B2 puncture using a conventional OV scope, a novel OV scope (EG-740UT), and a forward-viewing (FV) scope (TGF-UC260J). Methods: This single-center retrospective study investigated 319 consecutive patients in whom B2-EUS-HGS was attempted using an OV or FV between January 2017 and March 2024 at Aichi Cancer Center. Results: In B2-EUS-HGS, the use of enhanced endoscopes (TGF-UC260J and EG-740UT) resulted in a relatively high technical success rate of 93.6% (205/219) and an overall clinical success rate of 97.1% (199/205). The enhanced endoscope group demonstrated a significantly higher technical success rate ( Conclusions: B2-EUS-HGS using either an FV or novel OV scope showed comparable safety with a high technical and overall clinical success rate. The use of an FV or novel OV scope seems to be a suitable strategy for performing B2-EUS-HGS. Clinical Trial Registration: Study/trial registration and registration number were not applicable (N/A), as this study was a retrospective analysis using anonymized data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.